Halozyme Therapeutics | Spese Operative



Operating Expenses Cambiamento Data
Acadia Pharmaceuticals USD 225.03M 118.93M 2025-03
Agios Pharmaceuticals USD 115.35M 20.41M 2025-03
Alnylam Pharmaceuticals USD 576.11M 122.21M 2025-03
Amarin USD 67.47M 549K 2024-09
Amgen USD 6.86B 85M 2025-03
Baxter International USD 3.19B 644M 2024-12
Cytokinetics USD 157.21M 1.24M 2025-03
DBV Technologies USD 31.4M 3.6M 2024-09
Eli Lilly USD 7.32B 1.06B 2025-03
Halozyme Therapeutics USD 123.33M 819K 2025-03
Indivior 200M 193M 2025-03
Ionis Pharmaceuticals USD 278M 59.4M 2025-03
MannKind USD 63.68M 11.62M 2024-12
Pfizer USD 10.05B 8.12B 2025-03
United Therapeutics USD 411.6M 33.4M 2025-03



Halozyme Therapeutics Spese Operative - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.